Quản lý chống đông máu bởi dược sĩ cộng đồng tại New Zealand: đánh giá mô hình hợp tác trong chăm sóc ban đầu

Young, 2004, Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?, Intern Med J, 34, 639, 10.1111/j.1445-5994.2004.00690.x

Baker, 2009, Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States, J Manag Care Pharm, 15, 244, 10.18553/jmcp.2009.15.3.244

Van Walraven, 2006, Effect of study setting on anticoagulation control: a systematic review and metaregression, Chest, 129, 1155, 10.1378/chest.129.5.1155

Connolly, 2008, Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range, Circulation, 118, 2029, 10.1161/CIRCULATIONAHA.107.750000

Dolan, 2008, Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature, Curr Med Res Opin, 24, 1459, 10.1185/030079908X297349

Bond, 2004, Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions, Pharmacotherapy, 24, 953, 10.1592/phco.24.11.953.36133

Matchar, 2002, Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial, Am J Med, 113, 42, 10.1016/S0002-9343(02)01131-2

Wilson, 2003, Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial, CMAJ, 169, 293

Chiquette, 1998, Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs, Arch Intern Med, 158, 1641, 10.1001/archinte.158.15.1641

Witt, 2005, Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy, Chest, 127, 1515, 10.1378/chest.127.5.1515

Bungard, 2009, Evaluation of a pharmacist-managed anticoagulation clinic: improving patient care, Open Med, 3, e16

Airee, 2009, Clinical outcomes and pharmacists' acceptance of a community hospital’s anticoagulation management service utilizing decentralized clinical staff pharmacists, Ann Pharmacother, 43, 621, 10.1345/aph.1L460

Willey, 2003, A pharmacist-managed anticoagulation clinic: six-year assessment of patient outcomes, Am J Health Syst Pharm, 60, 1033, 10.1093/ajhp/60.10.1033

Saokaew, 2010, Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis, J Thromb Haemost, 8, 2418, 10.1111/j.1538-7836.2010.04051.x

Holden, 2000, Comparative effectiveness of general practitioner versus pharmacist dosing of patients requiring anticoagulation in the community, J Clin Pharm Ther, 25, 49, 10.1046/j.1365-2710.2000.00262.x

Young, 2011, Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic, BMC Fam Pract, 12, 88, 10.1186/1471-2296-12-88

Wilt, 1995, Outcome analysis of a pharmacist-managed anticoagulation service, Pharmacotherapy, 15, 732, 10.1002/j.1875-9114.1995.tb02889.x

Macgregor, 1996, Evaluation of a primary care anticoagulant clinic managed by a pharmacist, BMJ, 312, 560, 10.1136/bmj.312.7030.560

Amruso, 2004, Ability of clinical pharmacists in a community pharmacy setting to manage anticoagulation therapy, J Am Pharm Assoc (2003), 44, 467, 10.1331/1544345041475751

Coleman, 2004, An evaluation of the safety and acceptability of an anticoagulation clinic in a community pharmacy setting – a pilot study, Pharm J, 273, 822

Bungard, 2006, Bringing the benefits of anticoagulation management to the community, Can Pharm J, 139, 58, 10.1177/171516350613900207

Knowlton, 1999, Establishing community pharmacy-based anticoagulation education and monitoring programs, J Am Pharm Assoc, 39, 368

Jackson, 2005, Improving the outcomes of anticoagulation in rural Australia: an evaluation of pharmacist-assisted monitoring of warfarin therapy, J Clin Pharm Ther, 30, 345, 10.1111/j.1365-2710.2005.00656.x

Rosendaal, 1993, A method to determine the optimal intensity of oral anticoagulant therapy, Thromb Haemost, 69, 236, 10.1055/s-0038-1651587

Baglin, 2007, Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency, Br J Haematol, 136, 26, 10.1111/j.1365-2141.2006.06379.x

Wieloch, 2011, Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA, Eur Heart J, 32, 2282, 10.1093/eurheartj/ehr134

Shalev, 2007, The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation, Thromb Res, 120, 201, 10.1016/j.thromres.2006.10.001

Holbrook, 2012, Evidence-based management of anticoagulant therapy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines, Chest, 141, e152S, 10.1378/chest.11-2295

Wan, 2008, Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review, Circ Cardiovasc Qual Outcomes, 1, 84, 10.1161/CIRCOUTCOMES.108.796185

Alsheikh-Ali, 2008, Anticoagulation control in atrial fibrillation: optimizing risks and benefits, Circ Cardiovasc Qual Outcomes, 1, 72, 10.1161/CIRCOUTCOMES.108.827329

Van Den Ham, 2013, The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation, J Thromb Haemost, 11, 107, 10.1111/jth.12041

Shaw, 2014, A community pharmacist-led anticoagulation management service: attitudes towards a new collaborative model of care in New Zealand, Int J Pharm Prac, 10.1111/ijpp.12097

Van Spall, 2012, Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY), Circulation, 126, 2309, 10.1161/CIRCULATIONAHA.112.101808

Heneghan, 2012, Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data, Lancet, 379, 322, 10.1016/S0140-6736(11)61294-4

Connock, 2007, Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling, Health Technol Assess, 11, iii, 10.3310/hta11380